Adam Boehler Purchases 277,565 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Adam Boehler purchased 277,565 shares of Privia Health Group stock in a transaction dated Tuesday, May 21st. The shares were purchased at an average cost of $16.17 per share, with a total value of $4,488,226.05. Following the acquisition, the director now owns 5,488,701 shares of the company’s stock, valued at approximately $88,752,295.17. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Privia Health Group Trading Up 7.4 %

NASDAQ PRVA opened at $17.31 on Friday. The stock’s 50-day moving average price is $18.40 and its two-hundred day moving average price is $20.62. The company has a market cap of $2.07 billion, a PE ratio of 115.40, a PEG ratio of 2.37 and a beta of 0.81. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $29.42.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The company had revenue of $440.80 million for the quarter, compared to analyst estimates of $425.81 million. Privia Health Group had a return on equity of 3.13% and a net margin of 1.11%. Privia Health Group’s quarterly revenue was up 21.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.14 EPS. Research analysts forecast that Privia Health Group, Inc. will post 0.21 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. TD Cowen reduced their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a report on Friday, March 1st. Stifel Nicolaus reduced their price objective on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Bank of America downgraded shares of Privia Health Group from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $27.00 to $21.00 in a report on Thursday, February 22nd. UBS Group reduced their price objective on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating for the company in a report on Friday, March 1st. Finally, Truist Financial reduced their price objective on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average price target of $25.08.

Institutional Trading of Privia Health Group

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Covestor Ltd raised its holdings in Privia Health Group by 8.3% during the 3rd quarter. Covestor Ltd now owns 6,703 shares of the company’s stock worth $154,000 after buying an additional 514 shares during the period. Yousif Capital Management LLC increased its holdings in shares of Privia Health Group by 1.1% in the 4th quarter. Yousif Capital Management LLC now owns 52,628 shares of the company’s stock valued at $1,212,000 after purchasing an additional 563 shares during the period. New York State Common Retirement Fund increased its holdings in shares of Privia Health Group by 2.7% in the 3rd quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock valued at $643,000 after purchasing an additional 737 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Privia Health Group by 9.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock valued at $176,000 after purchasing an additional 756 shares during the period. Finally, Glenmede Trust Co. NA increased its holdings in shares of Privia Health Group by 0.9% in the 3rd quarter. Glenmede Trust Co. NA now owns 107,711 shares of the company’s stock valued at $2,477,000 after purchasing an additional 976 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.